2003•Journal of Qilu OncologyRequires access

Advances of Angiostation in the Treatment of Solid Tumor

Shaopeng Qiu

Abstract

Angiostatin is a angiogenesis inhibiting factor derived from tumor, which can potently inhibit endothelial cell proliferation and migration and has an important application value in the treatment of solid tumor. This paper reviews the current research situation of angiostatin, the relationship between angiostatin and angiogenesis of solid tumor and the respect of application in cancer anti-vascular therapy. China J Cancer Prev Treat,2003,10(3):332-334

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Angiostatin, Angiogenesis, Solid tumor, Cancer research, Cancer therapy, Tumor cells, Cancer, Vascular endothelial growth factor